Long-Term Analysis of Clinical Features and Treatment Outcomes of Inflammatory Choroidal Neovascularization
• The overall visual outcome of inflammatory choroidal neovascularization (CNV) was relatively good, and the recurrence of inflammatory CNV showed higher rates over time after anti-VEGF treatment than previously reported. • Baseline best-corrected visual acuity and retinal pigment epithelium atrophy...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Kim, Mirinae [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2022 |
|---|
| Umfang: |
12 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Net neutrality and CDN intermediation - Baake, Pio ELSEVIER, 2019, AJO, New York, NY |
|---|---|
| Übergeordnetes Werk: |
volume:233 ; year:2022 ; pages:18-29 ; extent:12 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.ajo.2021.07.014 |
|---|
| Katalog-ID: |
ELV056233531 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV056233531 | ||
| 003 | DE-627 | ||
| 005 | 20230624230546.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220105s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ajo.2021.07.014 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001612.pica |
| 035 | |a (DE-627)ELV056233531 | ||
| 035 | |a (ELSEVIER)S0002-9394(21)00381-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 300 |a 330 |q VZ |
| 084 | |a 83.00 |2 bkl | ||
| 084 | |a 85.00 |2 bkl | ||
| 084 | |a 83.11 |2 bkl | ||
| 100 | 1 | |a Kim, Mirinae |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Long-Term Analysis of Clinical Features and Treatment Outcomes of Inflammatory Choroidal Neovascularization |
| 264 | 1 | |c 2022 | |
| 300 | |a 12 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • The overall visual outcome of inflammatory choroidal neovascularization (CNV) was relatively good, and the recurrence of inflammatory CNV showed higher rates over time after anti-VEGF treatment than previously reported. • Baseline best-corrected visual acuity and retinal pigment epithelium atrophy or absence after treatment are significant predictors for the visual outcome. • Intraretinal hyperreflective foci after anti-VEGF treatment suggests the potential risk of recurrence. | ||
| 700 | 1 | |a Lee, Junhyuck |4 oth | |
| 700 | 1 | |a Park, Young-Gun |4 oth | |
| 700 | 1 | |a Park, Young-Hoon |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Baake, Pio ELSEVIER |t Net neutrality and CDN intermediation |d 2019 |d AJO |g New York, NY |w (DE-627)ELV001956566 |
| 773 | 1 | 8 | |g volume:233 |g year:2022 |g pages:18-29 |g extent:12 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ajo.2021.07.014 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 936 | b | k | |a 83.00 |j Volkswirtschaft: Allgemeines |q VZ |
| 936 | b | k | |a 85.00 |j Betriebswirtschaft: Allgemeines |q VZ |
| 936 | b | k | |a 83.11 |j Mikroökonomie |q VZ |
| 951 | |a AR | ||
| 952 | |d 233 |j 2022 |h 18-29 |g 12 | ||
| author_variant |
m k mk |
|---|---|
| matchkey_str |
kimmirinaeleejunhyuckparkyounggunparkyou:2022----:ogemnlssflncletrsntetetucmsfnlmaoy |
| hierarchy_sort_str |
2022 |
| bklnumber |
83.00 85.00 83.11 |
| publishDate |
2022 |
| allfields |
10.1016/j.ajo.2021.07.014 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001612.pica (DE-627)ELV056233531 (ELSEVIER)S0002-9394(21)00381-0 DE-627 ger DE-627 rakwb eng 300 330 VZ 83.00 bkl 85.00 bkl 83.11 bkl Kim, Mirinae verfasserin aut Long-Term Analysis of Clinical Features and Treatment Outcomes of Inflammatory Choroidal Neovascularization 2022 12 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • The overall visual outcome of inflammatory choroidal neovascularization (CNV) was relatively good, and the recurrence of inflammatory CNV showed higher rates over time after anti-VEGF treatment than previously reported. • Baseline best-corrected visual acuity and retinal pigment epithelium atrophy or absence after treatment are significant predictors for the visual outcome. • Intraretinal hyperreflective foci after anti-VEGF treatment suggests the potential risk of recurrence. Lee, Junhyuck oth Park, Young-Gun oth Park, Young-Hoon oth Enthalten in Elsevier Science Baake, Pio ELSEVIER Net neutrality and CDN intermediation 2019 AJO New York, NY (DE-627)ELV001956566 volume:233 year:2022 pages:18-29 extent:12 https://doi.org/10.1016/j.ajo.2021.07.014 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 83.00 Volkswirtschaft: Allgemeines VZ 85.00 Betriebswirtschaft: Allgemeines VZ 83.11 Mikroökonomie VZ AR 233 2022 18-29 12 |
| spelling |
10.1016/j.ajo.2021.07.014 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001612.pica (DE-627)ELV056233531 (ELSEVIER)S0002-9394(21)00381-0 DE-627 ger DE-627 rakwb eng 300 330 VZ 83.00 bkl 85.00 bkl 83.11 bkl Kim, Mirinae verfasserin aut Long-Term Analysis of Clinical Features and Treatment Outcomes of Inflammatory Choroidal Neovascularization 2022 12 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • The overall visual outcome of inflammatory choroidal neovascularization (CNV) was relatively good, and the recurrence of inflammatory CNV showed higher rates over time after anti-VEGF treatment than previously reported. • Baseline best-corrected visual acuity and retinal pigment epithelium atrophy or absence after treatment are significant predictors for the visual outcome. • Intraretinal hyperreflective foci after anti-VEGF treatment suggests the potential risk of recurrence. Lee, Junhyuck oth Park, Young-Gun oth Park, Young-Hoon oth Enthalten in Elsevier Science Baake, Pio ELSEVIER Net neutrality and CDN intermediation 2019 AJO New York, NY (DE-627)ELV001956566 volume:233 year:2022 pages:18-29 extent:12 https://doi.org/10.1016/j.ajo.2021.07.014 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 83.00 Volkswirtschaft: Allgemeines VZ 85.00 Betriebswirtschaft: Allgemeines VZ 83.11 Mikroökonomie VZ AR 233 2022 18-29 12 |
| allfields_unstemmed |
10.1016/j.ajo.2021.07.014 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001612.pica (DE-627)ELV056233531 (ELSEVIER)S0002-9394(21)00381-0 DE-627 ger DE-627 rakwb eng 300 330 VZ 83.00 bkl 85.00 bkl 83.11 bkl Kim, Mirinae verfasserin aut Long-Term Analysis of Clinical Features and Treatment Outcomes of Inflammatory Choroidal Neovascularization 2022 12 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • The overall visual outcome of inflammatory choroidal neovascularization (CNV) was relatively good, and the recurrence of inflammatory CNV showed higher rates over time after anti-VEGF treatment than previously reported. • Baseline best-corrected visual acuity and retinal pigment epithelium atrophy or absence after treatment are significant predictors for the visual outcome. • Intraretinal hyperreflective foci after anti-VEGF treatment suggests the potential risk of recurrence. Lee, Junhyuck oth Park, Young-Gun oth Park, Young-Hoon oth Enthalten in Elsevier Science Baake, Pio ELSEVIER Net neutrality and CDN intermediation 2019 AJO New York, NY (DE-627)ELV001956566 volume:233 year:2022 pages:18-29 extent:12 https://doi.org/10.1016/j.ajo.2021.07.014 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 83.00 Volkswirtschaft: Allgemeines VZ 85.00 Betriebswirtschaft: Allgemeines VZ 83.11 Mikroökonomie VZ AR 233 2022 18-29 12 |
| allfieldsGer |
10.1016/j.ajo.2021.07.014 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001612.pica (DE-627)ELV056233531 (ELSEVIER)S0002-9394(21)00381-0 DE-627 ger DE-627 rakwb eng 300 330 VZ 83.00 bkl 85.00 bkl 83.11 bkl Kim, Mirinae verfasserin aut Long-Term Analysis of Clinical Features and Treatment Outcomes of Inflammatory Choroidal Neovascularization 2022 12 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • The overall visual outcome of inflammatory choroidal neovascularization (CNV) was relatively good, and the recurrence of inflammatory CNV showed higher rates over time after anti-VEGF treatment than previously reported. • Baseline best-corrected visual acuity and retinal pigment epithelium atrophy or absence after treatment are significant predictors for the visual outcome. • Intraretinal hyperreflective foci after anti-VEGF treatment suggests the potential risk of recurrence. Lee, Junhyuck oth Park, Young-Gun oth Park, Young-Hoon oth Enthalten in Elsevier Science Baake, Pio ELSEVIER Net neutrality and CDN intermediation 2019 AJO New York, NY (DE-627)ELV001956566 volume:233 year:2022 pages:18-29 extent:12 https://doi.org/10.1016/j.ajo.2021.07.014 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 83.00 Volkswirtschaft: Allgemeines VZ 85.00 Betriebswirtschaft: Allgemeines VZ 83.11 Mikroökonomie VZ AR 233 2022 18-29 12 |
| allfieldsSound |
10.1016/j.ajo.2021.07.014 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001612.pica (DE-627)ELV056233531 (ELSEVIER)S0002-9394(21)00381-0 DE-627 ger DE-627 rakwb eng 300 330 VZ 83.00 bkl 85.00 bkl 83.11 bkl Kim, Mirinae verfasserin aut Long-Term Analysis of Clinical Features and Treatment Outcomes of Inflammatory Choroidal Neovascularization 2022 12 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • The overall visual outcome of inflammatory choroidal neovascularization (CNV) was relatively good, and the recurrence of inflammatory CNV showed higher rates over time after anti-VEGF treatment than previously reported. • Baseline best-corrected visual acuity and retinal pigment epithelium atrophy or absence after treatment are significant predictors for the visual outcome. • Intraretinal hyperreflective foci after anti-VEGF treatment suggests the potential risk of recurrence. Lee, Junhyuck oth Park, Young-Gun oth Park, Young-Hoon oth Enthalten in Elsevier Science Baake, Pio ELSEVIER Net neutrality and CDN intermediation 2019 AJO New York, NY (DE-627)ELV001956566 volume:233 year:2022 pages:18-29 extent:12 https://doi.org/10.1016/j.ajo.2021.07.014 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 83.00 Volkswirtschaft: Allgemeines VZ 85.00 Betriebswirtschaft: Allgemeines VZ 83.11 Mikroökonomie VZ AR 233 2022 18-29 12 |
| language |
English |
| source |
Enthalten in Net neutrality and CDN intermediation New York, NY volume:233 year:2022 pages:18-29 extent:12 |
| sourceStr |
Enthalten in Net neutrality and CDN intermediation New York, NY volume:233 year:2022 pages:18-29 extent:12 |
| format_phy_str_mv |
Article |
| bklname |
Volkswirtschaft: Allgemeines Betriebswirtschaft: Allgemeines Mikroökonomie |
| institution |
findex.gbv.de |
| dewey-raw |
300 |
| isfreeaccess_bool |
false |
| container_title |
Net neutrality and CDN intermediation |
| authorswithroles_txt_mv |
Kim, Mirinae @@aut@@ Lee, Junhyuck @@oth@@ Park, Young-Gun @@oth@@ Park, Young-Hoon @@oth@@ |
| publishDateDaySort_date |
2022-01-01T00:00:00Z |
| hierarchy_top_id |
ELV001956566 |
| dewey-sort |
3300 |
| id |
ELV056233531 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV056233531</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624230546.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220105s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ajo.2021.07.014</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001612.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV056233531</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0002-9394(21)00381-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">300</subfield><subfield code="a">330</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">83.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">85.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">83.11</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Kim, Mirinae</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Long-Term Analysis of Clinical Features and Treatment Outcomes of Inflammatory Choroidal Neovascularization</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">12</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• The overall visual outcome of inflammatory choroidal neovascularization (CNV) was relatively good, and the recurrence of inflammatory CNV showed higher rates over time after anti-VEGF treatment than previously reported. • Baseline best-corrected visual acuity and retinal pigment epithelium atrophy or absence after treatment are significant predictors for the visual outcome. • Intraretinal hyperreflective foci after anti-VEGF treatment suggests the potential risk of recurrence.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lee, Junhyuck</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Park, Young-Gun</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Park, Young-Hoon</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Baake, Pio ELSEVIER</subfield><subfield code="t">Net neutrality and CDN intermediation</subfield><subfield code="d">2019</subfield><subfield code="d">AJO</subfield><subfield code="g">New York, NY</subfield><subfield code="w">(DE-627)ELV001956566</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:233</subfield><subfield code="g">year:2022</subfield><subfield code="g">pages:18-29</subfield><subfield code="g">extent:12</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ajo.2021.07.014</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">83.00</subfield><subfield code="j">Volkswirtschaft: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">85.00</subfield><subfield code="j">Betriebswirtschaft: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">83.11</subfield><subfield code="j">Mikroökonomie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">233</subfield><subfield code="j">2022</subfield><subfield code="h">18-29</subfield><subfield code="g">12</subfield></datafield></record></collection>
|
| author |
Kim, Mirinae |
| spellingShingle |
Kim, Mirinae ddc 300 bkl 83.00 bkl 85.00 bkl 83.11 Long-Term Analysis of Clinical Features and Treatment Outcomes of Inflammatory Choroidal Neovascularization |
| authorStr |
Kim, Mirinae |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV001956566 |
| format |
electronic Article |
| dewey-ones |
300 - Social sciences 330 - Economics |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
300 330 VZ 83.00 bkl 85.00 bkl 83.11 bkl Long-Term Analysis of Clinical Features and Treatment Outcomes of Inflammatory Choroidal Neovascularization |
| topic |
ddc 300 bkl 83.00 bkl 85.00 bkl 83.11 |
| topic_unstemmed |
ddc 300 bkl 83.00 bkl 85.00 bkl 83.11 |
| topic_browse |
ddc 300 bkl 83.00 bkl 85.00 bkl 83.11 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
j l jl y g p ygp y h p yhp |
| hierarchy_parent_title |
Net neutrality and CDN intermediation |
| hierarchy_parent_id |
ELV001956566 |
| dewey-tens |
300 - Social sciences, sociology & anthropology 330 - Economics |
| hierarchy_top_title |
Net neutrality and CDN intermediation |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV001956566 |
| title |
Long-Term Analysis of Clinical Features and Treatment Outcomes of Inflammatory Choroidal Neovascularization |
| ctrlnum |
(DE-627)ELV056233531 (ELSEVIER)S0002-9394(21)00381-0 |
| title_full |
Long-Term Analysis of Clinical Features and Treatment Outcomes of Inflammatory Choroidal Neovascularization |
| author_sort |
Kim, Mirinae |
| journal |
Net neutrality and CDN intermediation |
| journalStr |
Net neutrality and CDN intermediation |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
300 - Social sciences |
| recordtype |
marc |
| publishDateSort |
2022 |
| contenttype_str_mv |
zzz |
| container_start_page |
18 |
| author_browse |
Kim, Mirinae |
| container_volume |
233 |
| physical |
12 |
| class |
300 330 VZ 83.00 bkl 85.00 bkl 83.11 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Kim, Mirinae |
| doi_str_mv |
10.1016/j.ajo.2021.07.014 |
| dewey-full |
300 330 |
| title_sort |
long-term analysis of clinical features and treatment outcomes of inflammatory choroidal neovascularization |
| title_auth |
Long-Term Analysis of Clinical Features and Treatment Outcomes of Inflammatory Choroidal Neovascularization |
| abstract |
• The overall visual outcome of inflammatory choroidal neovascularization (CNV) was relatively good, and the recurrence of inflammatory CNV showed higher rates over time after anti-VEGF treatment than previously reported. • Baseline best-corrected visual acuity and retinal pigment epithelium atrophy or absence after treatment are significant predictors for the visual outcome. • Intraretinal hyperreflective foci after anti-VEGF treatment suggests the potential risk of recurrence. |
| abstractGer |
• The overall visual outcome of inflammatory choroidal neovascularization (CNV) was relatively good, and the recurrence of inflammatory CNV showed higher rates over time after anti-VEGF treatment than previously reported. • Baseline best-corrected visual acuity and retinal pigment epithelium atrophy or absence after treatment are significant predictors for the visual outcome. • Intraretinal hyperreflective foci after anti-VEGF treatment suggests the potential risk of recurrence. |
| abstract_unstemmed |
• The overall visual outcome of inflammatory choroidal neovascularization (CNV) was relatively good, and the recurrence of inflammatory CNV showed higher rates over time after anti-VEGF treatment than previously reported. • Baseline best-corrected visual acuity and retinal pigment epithelium atrophy or absence after treatment are significant predictors for the visual outcome. • Intraretinal hyperreflective foci after anti-VEGF treatment suggests the potential risk of recurrence. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| title_short |
Long-Term Analysis of Clinical Features and Treatment Outcomes of Inflammatory Choroidal Neovascularization |
| url |
https://doi.org/10.1016/j.ajo.2021.07.014 |
| remote_bool |
true |
| author2 |
Lee, Junhyuck Park, Young-Gun Park, Young-Hoon |
| author2Str |
Lee, Junhyuck Park, Young-Gun Park, Young-Hoon |
| ppnlink |
ELV001956566 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth |
| doi_str |
10.1016/j.ajo.2021.07.014 |
| up_date |
2024-07-06T19:48:43.875Z |
| _version_ |
1803860389528600576 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV056233531</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624230546.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220105s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ajo.2021.07.014</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001612.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV056233531</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0002-9394(21)00381-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">300</subfield><subfield code="a">330</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">83.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">85.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">83.11</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Kim, Mirinae</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Long-Term Analysis of Clinical Features and Treatment Outcomes of Inflammatory Choroidal Neovascularization</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">12</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• The overall visual outcome of inflammatory choroidal neovascularization (CNV) was relatively good, and the recurrence of inflammatory CNV showed higher rates over time after anti-VEGF treatment than previously reported. • Baseline best-corrected visual acuity and retinal pigment epithelium atrophy or absence after treatment are significant predictors for the visual outcome. • Intraretinal hyperreflective foci after anti-VEGF treatment suggests the potential risk of recurrence.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lee, Junhyuck</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Park, Young-Gun</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Park, Young-Hoon</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Baake, Pio ELSEVIER</subfield><subfield code="t">Net neutrality and CDN intermediation</subfield><subfield code="d">2019</subfield><subfield code="d">AJO</subfield><subfield code="g">New York, NY</subfield><subfield code="w">(DE-627)ELV001956566</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:233</subfield><subfield code="g">year:2022</subfield><subfield code="g">pages:18-29</subfield><subfield code="g">extent:12</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ajo.2021.07.014</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">83.00</subfield><subfield code="j">Volkswirtschaft: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">85.00</subfield><subfield code="j">Betriebswirtschaft: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">83.11</subfield><subfield code="j">Mikroökonomie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">233</subfield><subfield code="j">2022</subfield><subfield code="h">18-29</subfield><subfield code="g">12</subfield></datafield></record></collection>
|
| score |
7.399646 |